Literature DB >> 1716516

Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin.

F Oyama1, S Hirohashi, Y Shimosato, K Titani, K Sekiguchi.   

Abstract

Qualitative and quantitative alterations of human tenascin (TN) expression in virally transformed lung fibroblasts and in lung tumor tissues were investigated using S1 nuclease protection analysis in comparison with those of fibronectin (FN). Transformed fibroblasts and fetal lung tissues expressed more TN mRNA with an extra sequence encoding the sixth FN type III repeat than did normal cells and adult tissues. The splicing pattern of TN mRNA was also altered in many lung cancer tissues, showing increased or sometimes decreased expression of the TN mRNA with the extra sequence when compared with their surrounding normal tissues. These results provide additional evidence for the oncodevelopmental regulation of alternative RNA splicing in human lung tissues, first observed with FN mRNA (F. Oyama, et al., Cancer Res., 50: 1075-1078, 1990). Quantitative analysis of the levels of TN and FN mRNAs showed that the ratio of TN mRNA to FN mRNA was significantly increased in transformed fibroblasts and in some lung tumor tissues, when compared with their normal counterparts. Among different types of lung tumors, a significant increase of the TN/FN ratio was observed with most squamous cell carcinoma but with only a small fraction of adenocarcinoma. Since TN has been shown to inhibit cell adhesion to FN, the altered ratio of TN mRNA to FN mRNA may well affect the adhesive and migratory properties of tumor cells in lung cancer tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716516

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices.

Authors:  P Sriramarao; M A Bourdon
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

2.  Trichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells.

Authors:  Ashwini Kucknoor; Vasanthakrishna Mundodi; John F Alderete
Journal:  Cell Microbiol       Date:  2005-06       Impact factor: 3.715

3.  Tenascin-C and human tendon degeneration.

Authors:  G P Riley; R L Harrall; T E Cawston; B L Hazleman; E J Mackie
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

Review 4.  Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.

Authors:  Pomila Singh
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

Review 5.  Tenascins, a growing family of extracellular matrix proteins.

Authors:  R Chiquet-Ehrismann
Journal:  Experientia       Date:  1995-09-29

6.  Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues.

Authors:  M Chilosi; M Lestani; A Benedetti; L Montagna; S Pedron; A Scarpa; F Menestrina; S Hirohashi; G Pizzolo; G Semenzato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

7.  Expression and degeneration of tenascin-C in human lung cancers.

Authors:  H Kusagawa; K Onoda; S Namikawa; I Yada; A Okada; T Yoshida; T Sakakura
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

8.  Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.

Authors:  Florian Gebauer; Suyin Gelis; Hilke Zander; Karl-Frederick Meyer; Gerrit Wolters-Eisfeld; Jakob R Izbicki; Maximilian Bockhorn; Michael Tachezy
Journal:  Oncotarget       Date:  2016-04-12

9.  Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C.

Authors:  C Y Chung; H P Erickson
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

Review 10.  Tenascin-C: Form versus function.

Authors:  Sean P Giblin; Kim S Midwood
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.